Lakshmanan Krishnamurti
Pediatric Hematology-Oncology · Atlanta, GANPI 1992779334
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Bioverativ Therapeutics Inc. at 36.9% of the total. Reporting peaked in 2019 at $15,658 and has fallen 99.7% since, to $42 in 2025.
Across 28 payments — averaging $772.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioverativ Therapeutics Inc.$8K
- CSL Behring$6K
- Vertex$6K
- Pfizer$1K
- Novartis$145
- Genetix Biotherapeutics Inc$125
- plus $89 from 1 others
Across 94 payments — averaging $3974.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bioverativ Therapeutics Inc.$162K
- Genetix Biotherapeutics Inc$73K
- Global Blood Therapeutics, Inc.$46K
- CSL Behring$26K
- Agios Pharmaceuticals, Inc.$22K
- National Marrow Donor Program$16K
- plus $29K from 2 others
What the payments were for
- Consulting fees$12,83659%
- Speaking & faculty fees$4,70022%
- Travel & lodging$3,08514%
- Food & beverage$1,0105%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioverativ Therapeutics Inc. | 8 | $7,988 |
| CSL Behring | 5 | $6,475 |
| Vertex | 10 | $5,758 |
| Pfizer | 2 | $1,050 |
| Novartis | 1 | $145 |
| Genetix Biotherapeutics Inc | 1 | $125 |
| Sobi, Inc | 1 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO PRODUCT DISCUSSED$7,754
How this compares
$21,630 in reported general payments places this provider in the 85th percentile of 74 pediatric hematology-oncology providers in Georgia.
See all pediatric hematology-oncology providers in Georgia →
Other pediatric hematology-oncology in Atlanta
- Robert SidonioAtlanta$834K
- Shannon MeeksAtlanta$255K
- Bhavya DoshiAtlanta$200K
- Muna QayedAtlanta$86K
- Shanmuganathan ChandrakasanAtlanta$67K
- Vivien SheehanAtlanta$51K
- Carlton DampierAtlanta$30K
- William CashAtlanta$28K
- Megan BrownAtlanta$24K
- Carolyn BennettAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.